DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, LeVan L.
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Prostate 2013;
73: 970-978
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.